SHULGAU, Z.; KAMYSHANSKIY , Y.; GULYAYEV, A. POSSIBILITIES OF USING MEDICINES AND BIOLOGICALLY ACTIVE SUBSTANCES AS CORRECTIVES FOR THE FORMATION OF PULMONARY FIBROSIS DURING SARS-COV-2 INFECTION AND IN THE POST-COVID PERIOD. Eurasian Journal of Applied Biotechnology, [S. l.], n. 1, p. 3–26, 2023. DOI: 10.11134/btp.1.2023.1. Disponível em: https://biotechlink.org/index.php/journal/article/view/334. Acesso em: 23 nov. 2024.